ClinicalTrials.gg
RecruitingNCT05255289Updated Sep 5, 2025

Efficacy/Safety of Midurethral Sling

An interventional study of Urodynamic investigations before and after a trans-obturator tape protocol. and Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O) in Stress Urinary Incontinence, sponsored by Mackay Medical College. Recruiting at 1 site in Taiwan. Open to female participants aged 30 Years to 100 Years. Per ClinicalTrials.gov, last updated 2025-09-05.

Sponsored by Mackay Medical College · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Mar 2026, 8 months ago, but the record still lists the study as recruiting.
  • Registered 11 months after the study started (first participant enrolled Mar 2021, registered Feb 2022).
  • Started Mar 2021; still recruiting 5 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Non-randomized
Ages
30 Years to 100 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 18 studies in Urinary Incontinence, Stress with a site in Taiwan — 3 open to participants now, 3 under way, none of them phase 3. Urinary Incontinence, Stress · Taiwan.

Started
2021
with 1 other
No phase
6 of 18
1 open now
Registered
10th of 18
by date
Lead sponsor
1 of 18
Mackay Medical College

Among the 18 studies in Urinary Incontinence, Stress with a site in Taiwan, this one is one of 2 that started in 2021, is one of 6 with no phase, and was the 10th registered.

Urinary Incontinence, Stress

655 studies on the registry are indexed under Urinary Incontinence, Stress; 123 are open to participants now.

Browse Urinary Incontinence, Stress studies →

Open to participants now

3 of the 18 studies in Urinary Incontinence, Stress with a site in Taiwan are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 76 Urinary Incontinence, Stress studies recruiting now, 43 (57%) set no upper age limit and 18 (24%) stop at 75 or younger; 2 take children under 18; 16 take healthy volunteers.

This study: 30 Years to 100 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Urinary Incontinence, Stress with a site in Taiwan, or all of them as a file.
02

Study summary

The trans-obturator tape (TOT), which exhibits a satisfactory cure rate and a relatively diminished invasiveness, has been increasingly accepted as a surgical treatment of stress urinary incontinence (SUI) patients. Nevertheless, in contrast to the well-recognized therapeutic benefit of the enhanced resistance to the bladder continence during urine storage, if the voiding function of the bladder adapts to the TOT-enhanced outlet resistance has not been adequately investigated. This study retrospectively assayed the voiding efficacy of each voiding cycle, to clarify if the thermodynamic efficacy of the bladder was modified in response to the TOT surgery.

Read the detailed description

The urodynamic study included free uroflowmetry, postvoid residual, filling and voiding cystometry, and a urethral pressure profile. The filling cystometry and urethral pressure profile were performed with 37 degrees C normal saline similar to body temperature at an infusion rate of 80 ml/min. All patients received a pre- and a post-operative urodynamic evaluation, in which pre-operative evaluation was conducted 1-4 weeks before TOT procedure, and post-operative evaluation was done at 4-6 weeks follow-up.

Complete multichannel urodynamic studies including free uroflowmetry, filling and voiding cystometry, and urethral pressure profile was performed in each patient. The urodynamic parameters measured were the maximum flow rate (Qmax), voided volume, post-void residual volume (PVR), and detrusor pressure at Qmax (Pdet. Qmax). The filling cystometry and urethral pressure profile were performed with 37 degrees C normal saline at an infusion rate of 80 ml/min. All data were recorded and analyzed using a Medical Measurement Systems (MMS UD-200, Enschede, The Netherlands). All data in this study will be expressed as mean ± SEM. After checking the normality and variance of data, two-way ANOVAs were used to assess the difference in values among testing groups and time points; and post hoc Student-Newman-Keuls tests were used to compare the means of groups when there was a significant difference between groups. Significance was set at p\<0.05.

03

Conditions studied

  • Stress Urinary Incontinence
04

Who can participate

Ages eligible
30 Years to 100 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical diagnosis of stress urinary incontience
  • Have urodynamic investigations before and after operation.

Exclusion criteria

Exclusion Criteria:

  • Exclusion criteria will be a history of (1) cardiovascular, (2) neurological, or (3) other medical (such as diabetes or inflammation) problems as well as (4) patients who received a concomitant surgical procedure.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Before TOT

    Data obtained before the operation

    Procedure: Urodynamic investigations before and after a trans-obturator tape protocol.

  • Experimental
    After TOT

    Data obtained after the operation

    Procedure: Urodynamic investigations before and after a trans-obturator tape protocol.

  • Experimental
    Before TVT-O

    Data obtained before the operation.

    Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)

  • Experimental
    After TVT-O

    Data obtained after the operation.

    Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)

  • Experimental
    Aged patient (>50 y/o) before TVT-O

    Data obtained before the operation.

    Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)

  • Experimental
    Aged patient (>50 y/o) after TVT-O

    Data obtained after the operation.

    Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)

  • Experimental
    Young patients (<50 y/o) before TVT-O

    Data obtained before the operation.

    Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)

  • Experimental
    Young patients (<50 y/o) after TVT-O

    Data obtained after the operation.

    Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)

  • Experimental
    Menopausal patient before TVT-O

    Data obtained before the operation.

    Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)

  • Experimental
    Menopausal patient after TVT-O

    Data obtained after the operation.

    Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)

  • Experimental
    Pre-menopausal patient before TVT-O

    Data obtained before the operation.

    Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)

  • Experimental
    Pre-menopausal patients after TVT-O

    Data obtained after the operation.

    Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)

  • Experimental
    Before i-STOP

    Data obtained before the operation.

    Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.

  • Experimental
    After i-STOP

    Data obtained after the operation.

    Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.

  • Experimental
    Aged patient before i-STOP

    Data obtained before the operation.

    Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.

  • Experimental
    Aged patient after i-STOP

    Data obtained after the operation.

    Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.

  • Experimental
    Young patient before i-STOP

    Data obtained before the operation.

    Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.

  • Experimental
    Young patient after i-STOP

    Data obtained after the operation.

    Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.

  • Experimental
    Menopausal patient before i-STOP

    Data obtained before the operation.

    Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.

  • Experimental
    Menopausal patient after i-STOP

    Data obtained after the operation.

    Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.

  • Experimental
    Pre-menopausal patient before i-STOP

    Data obtained before the operation.

    Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.

  • Experimental
    Pre-menopausal patient after i-STOP

    Data obtained after the operation.

    Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.

  • Experimental
    Before mini Arc

    Data obtained before the operation.

    Procedure: Urodynamic investigations before and after a mini Arc protocol.

  • Experimental
    After mini Arc

    Data obtained after the operation.

    Procedure: Urodynamic investigations before and after a mini Arc protocol.

  • Experimental
    Age patient before mini Arc

    Data obtained before the operation.

    Procedure: Urodynamic investigations before and after a mini Arc protocol.

  • Experimental
    Age patient after mini Arc

    Data obtained after the operation.

    Procedure: Urodynamic investigations before and after a mini Arc protocol.

  • Experimental
    Young before mini Arc

    Data obtained before the operation.

    Procedure: Urodynamic investigations before and after a mini Arc protocol.

  • Experimental
    Young patient after mini Arc

    Data obtained after the operation.

    Procedure: Urodynamic investigations before and after a mini Arc protocol.

  • Experimental
    Menopausal patient before mini Arc

    Data obtained before the operation.

    Procedure: Urodynamic investigations before and after a mini Arc protocol.

  • Experimental
    Menopausal patient after mini Arc

    Data obtained after the operation.

    Procedure: Urodynamic investigations before and after a mini Arc protocol.

  • Experimental
    Pre-menopausal before mini Arc

    Data obtained before the operation.

    Procedure: Urodynamic investigations before and after a mini Arc protocol.

  • Experimental
    Pre-menopausal patient after mini Arc

    Data obtained after the operation.

    Procedure: Urodynamic investigations before and after a mini Arc protocol.

  • Experimental
    Before Solyx sling

    Data obtained before the operation

    Procedure: Urodynamic investigations before and after an Solyx sling protocol.

  • Experimental
    After Solyx sling

    Data obtained before the operation

    Procedure: Urodynamic investigations before and after an Solyx sling protocol.

Interventions

  • ProcedureUrodynamic investigations before and after a trans-obturator tape protocol.

    Urodynamic investigations (The urodynamic study included free uroflowmetry, postvoid residual, filling and voiding cystometry, and a urethral pressure profile. The filling cystometry and urethral pressure profile were performed with 37 degrees C normal saline similar to body temperature at an infusion rate of 80 ml/min.)

  • ProcedureUrodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)

    Urodynamic investigations (stated above.)

  • ProcedureUrodynamic investigations before and after a mini Arc protocol.

    Urodynamic investigations (stated above)

  • ProcedureUrodynamic investigations before and after an i-STOP mini adjustable sling protocol.

    Urodynamic investigations (stated above)

  • ProcedureUrodynamic investigations before and after an Solyx sling protocol.

    Urodynamic investigations (stated above.)

06

What researchers measure

Primary outcomes

  1. Pressure-volume study

    urine leakage.

    Time frame: within a voiding cycle (a cycle is about 30 to 60 minutes)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Abrams P, Andersson KE, Apostolidis A, Birder L, Bliss D, Brubaker L, Cardozo L, Castro-Diaz D, O'Connell PR, Cottenden A, Cotterill N, de Ridder D, Dmochowski R, Dumoulin C, Fader M, Fry C, Goldman H, Hanno P, Homma Y, Khullar V, Maher C, Milsom I, Newman D, Nijman RJM, Rademakers K, Robinson D, Rosier P, Rovner E, Salvatore S, Takeda M, Wagg A, Wagner T, Wein A; members of the committees. 6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: EVALUATION AND TREATMENT OF URINARY INCONTINENCE, PELVIC ORGAN PROLAPSE AND FAECAL INCONTINENCE. Neurourol Urodyn. 2018 Sep;37(7):2271-2272. doi: 10.1002/nau.23551. Epub 2018 Aug 14. No abstract available. PubMed 30106223 ↗
  • Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A; Standardisation Sub-committee of the International Continence Society. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167-78. doi: 10.1002/nau.10052. No abstract available. PubMed 11857671 ↗
  • Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A; Standardisation Sub-Committee of the International Continence Society. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003 Jan;61(1):37-49. doi: 10.1016/s0090-4295(02)02243-4. No abstract available. PubMed 12559262 ↗
  • Atis G, Arisan S, Ozagari A, Caskurlu T, Dalkilinc A, Ergenekon E. Tissue reaction of the rat urinary bladder to synthetic mesh materials. ScientificWorldJournal. 2009 Oct 2;9:1046-51. doi: 10.1100/tsw.2009.120. PubMed 19802500 ↗
  • de Leval J. Novel surgical technique for the treatment of female stress urinary incontinence: transobturator vaginal tape inside-out. Eur Urol. 2003 Dec;44(6):724-30. doi: 10.1016/j.eururo.2003.09.003. PubMed 14644127 ↗
  • Hsiao SM, Kuo HC. Predictors of further anti-incontinence interventions or transvaginal urethrolysis after a pubovaginal sling procedure in women with and without neurologic disorders. J Formos Med Assoc. 2021 Jul;120(7):1464-1477. doi: 10.1016/j.jfma.2020.12.029. Epub 2021 Jan 16. PubMed 33468403 ↗
  • Huang WC, Lau HH, Su TH. Did surgical failure and complications affect incontinence-related quality of life in women after transobturator sling procedure? Taiwan J Obstet Gynecol. 2018 Apr;57(2):295-299. doi: 10.1016/j.tjog.2018.02.020. PubMed 29673676 ↗
  • Medina CA, Costantini E, Petri E, Mourad S, Singla A, Rodriguez-Colorado S, Ortiz OC, Doumouchtsis SK. Evaluation and surgery for stress urinary incontinence: A FIGO working group report. Neurourol Urodyn. 2017 Feb;36(2):518-528. doi: 10.1002/nau.22960. Epub 2016 Mar 7. PubMed 26950893 ↗
  • Schimpf MO, Rahn DD, Wheeler TL, Patel M, White AB, Orejuela FJ, El-Nashar SA, Margulies RU, Gleason JL, Aschkenazi SO, Mamik MM, Ward RM, Balk EM, Sung VW; Society of Gynecologic Surgeons Systematic Review Group. Sling surgery for stress urinary incontinence in women: a systematic review and metaanalysis. Am J Obstet Gynecol. 2014 Jul;211(1):71.e1-71.e27. doi: 10.1016/j.ajog.2014.01.030. Epub 2014 Jan 30. PubMed 24487005 ↗
  • Ulmsten U, Henriksson L, Johnson P, Varhos G. An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 1996;7(2):81-5; discussion 85-6. doi: 10.1007/BF01902378. PubMed 8798092 ↗
  • Waltregny D, Gaspar Y, Reul O, Hamida W, Bonnet P, de Leval J. TVT-O for the treatment of female stress urinary incontinence: results of a prospective study after a 3-year minimum follow-up. Eur Urol. 2008 Feb;53(2):401-8. doi: 10.1016/j.eururo.2007.08.021. Epub 2007 Aug 21. PubMed 17728052 ↗
  • Lau HH, Lai CY, Peng HY, Hsieh MC, Su TH, Lee JJ, Lin TB. Modification of bladder thermodynamics in stress urinary incontinence patients submitted to trans-obturator tape: A retrospective study based on urodynamic assessment. Front Bioeng Biotechnol. 2022 Aug 19;10:912602. doi: 10.3389/fbioe.2022.912602. eCollection 2022. PubMed 36061421 ↗

Individual participant data

Plan to share: No — For we uncertain if this might violate personal information laws in our country.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2021 (actual). Primary completion is estimated for Mar 2026, 60 months after the start.

Of 227 non-industry interventional studies with no phase under Urinary Incontinence, Stress, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 60 months is above that.

Counting every sponsor, half of 268 studies reached it within 19 months; a quarter within 9 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 12, 2022
First posted
Feb 24, 2022
StartActual
Mar 8, 2021
Primary completionEst.
Mar 2026
CompletionEst.
Mar 2026
Last update
Sep 5, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05255289
Lead sponsor
Mackay Medical College
Responsible party
Chin-Tsung Shen (Head of administration, Mackay Medical College) — Principal investigator
First posted
Feb 24, 2022
Start date
Mar 8, 2021
Primary completion
Mar 2026 (estimated)
Completion
Mar 2026 (estimated)
Last update
Sep 5, 2025

Study contacts

Hui-Hsuan Lau, M.D.
Contact
huihsuan1220@gmail.com
+886-975-835928
Yi-Shing Leu, M.D.
study chair · Department of Ear, Nose, and Throat, MacKay Memorial Hospital, Taipei, Taiwan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion